Perennial Advisors, LLC Eli Lilly & CO Transaction History

Perennial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $40,996 - $50,451	-185 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $24,135 - $31,936	185 New	185 $31,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $27,050 - $31,289	-185 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $25,237 - $30,373	185 New	185 $30,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Perennial Advisors, LLC with notifications on news.